bèta
Trial Radar AI
De klinische studie NCT06571747 (KP-VACCINATE) voor Cardiovasculaire ziekten, Influenza, Sociaal gedrag is actief, niet rekruterend. Bekijk de kaartweergave van de Klinische Studies Radar en de AI-ontdekkingstools voor alle details. Of stel hier een vraag.
Eén studie komt overeen met de filtercriteria
Kaartweergave
Terug naar zoekresultaten

Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement (KP-VACCINATE) 3.668.428 Gerandomiseerd Observationeel Innovatief

Actief, niet rekruterend
Informatie over klinische studies is voornamelijk in het Engels beschikbaar. Trial Radar AI kan echter helpen! Klik op 'Leg studie uit' om de informatie over de studie te bekijken en te bespreken in de taal van uw keuze.
De klinische studie NCT06571747 (KP-VACCINATE) is een interventioneel studie bij Cardiovasculaire ziekten, Influenza, Sociaal gedrag met de status actief, niet rekruterend. Het doel is om 3.668.428 deelnemers te includeren vanaf 5 september 2024. De studie wordt geleid door Kaiser Permanente en de voltooiing is gepland op 31 maart 2026. Laatste update op ClinicalTrials.gov: 15 mei 2025.
Beknopte samenvatting
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed.

KP VACCINATE is...

Toon meer
Uitgebreide beschrijving
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular events and mortality in select populations. However, the potential population level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed.

KP VACCINATE is a mu...

Toon meer
Officiële titel

Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement

Aandoeningen
Cardiovasculaire ziektenInfluenzaSociaal gedrag
Publicaties
Wetenschappelijke artikelen en onderzoekspapers gepubliceerd over deze klinische studie:
Andere studie-ID's
  • KP-VACCINATE
NCT-ID
NCT06571747
Startdatum (Werkelijk)
2024-09-05
Laatste update geplaatst
2025-05-15
Verwachte einddatum
2026-03-31
Inschrijving (Geschat)
3.668.428
Studietype
Interventioneel
FASE
N.v.t.
Status
Actief, niet rekruterend
Trefwoorden
Vaccination
Nudges
Behavioral Science
Cardiovascular Disease
Myocardial Infarction
Heart Failure
Implementation Science
Primaire doel
Overige
Toewijzing
Gerandomiseerd
Interventiemodel
Parallel
Blindering
Drievoudig blind
Armen / Interventies
Deelnemersgroep/StudiearmInterventie/Behandeling
ExperimenteelCV Nudge/CV Nudge
Intervention arms will test the effects of a cardiovascular-focused nudge communication developed using behavioral economic principles. This arm will receive the cardiovascular-focused nudge communication at 2 different timepoints during the influenza season.
Cardiovascular-Focused Nudge Communication
Intervention arms will receive a behavioral economic rooted nudge communication highlighting the potential cardiovascular benefits of vaccination.
ExperimenteelCV Nudge/Usual Care
Intervention arms will test the effects of a cardiovascular-focused nudge communication developed using behavioral economic principles. This arm will receive the cardiovascular-focused nudge communication at first timepoint and then usual care communication at the second timepoint during the influenza season.
Cardiovascular-Focused Nudge Communication
Intervention arms will receive a behavioral economic rooted nudge communication highlighting the potential cardiovascular benefits of vaccination.
ExperimenteelUsual Care/CV Nudge
Intervention arms will test the effects of a cardiovascular-focused nudge communication developed using behavioral economic principles. This arm will receive the usual care communication at first timepoint and then cardiovascular-focused nudge communication at the second timepoint during the influenza season.
Cardiovascular-Focused Nudge Communication
Intervention arms will receive a behavioral economic rooted nudge communication highlighting the potential cardiovascular benefits of vaccination.
Geen interventieUsual Care/Usual Care
The usual care arm will receive standard-of-care communication encouraging vaccination at both timepoints during the influenza season.
N.v.t.
Primaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
Proportion of participants with documented influenza vaccine receipt
Proportion of participants with documented influenza vaccine receipt after randomization.
up to 8 months
Secundaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
Time to influenza vaccine receipt
Time from randomization to influenza vaccine receipt.
up to 8 months
Deelname-assistent
Geschiktheidscriteria

Leeftijd van deelnemers
Volwassene, Oudere volwassene
Minimumleeftijd
18 Years
Geslachten die in aanmerking komen voor de studie
Allen
Accepteert gezonde vrijwilligers
Ja
  1. Age ≥18 years
  2. Active KPNC or KPMAS member
  3. ≥6 months of continuous health plan coverage and prescription drug benefit before September 1, 2024
  4. Evidence of member access to the KP HealthConnect® Portal and/or a listed registered email address
  5. No documented influenza vaccination during the 2024-2025 influenza season prior to randomization

  1. Unable to receive or opted out of receiving health system messaging
  2. Other exclusion that prevents messaging outreach.
  3. Unknown service area or medical center affiliation.
Kaiser Permanente logoKaiser Permanente
Geen contactgegevens beschikbaar
2 Studielocaties in 1 landen

California

Kaiser Permanente Northern California, Pleasanton, California, 94588, United States

Maryland

Kaiser Permanente Mid Atlantic States, Bethesda, Maryland, 20852, United States